IRINA JOVEL: Open Payments
NPI 1205336963 · HESPERIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 64 payments from 13 companies in 2025. Trend: 2023 $143 · 2024 $1,108 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 25 | $623 |
| Regeneron Healthcare Solutions, Inc. | 5 | $208 |
| Phathom Pharmaceuticals, Inc. | 8 | $188 |
| ABBVIE INC. | 10 | $176 |
| Ipsen Biopharmaceuticals, Inc | 4 | $78 |
| EVOKE PHARMA, INC. | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Ardelyx, Inc. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $39 |
| RedHill Biopharma Inc. | 1 | $39 |
Products named: REZDIFFRA, DUPIXENT, VOQUEZNA, VIBERZI, IQIRVO, GIMOTI, ENTYVIO, IBSRELA.
Industry payments across CA — which companies pay providers there.
